Search filters

List of works by Marcia Hall

A biomarker-enriched, randomized Phase II trial of adavosertib (AZD1775) plus paclitaxel and carboplatin for women with platinum-sensitive TP53-mutant ovarian cancer

scientific article published on 01 July 2020

A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG ⬇️

scientific article published on October 5, 2012

A phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours: a study protocol

scientific article

A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer

scientific article

An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients ⬇️

scientific article (publication date: 2016)

An unusual case of sex cord tumor with annular tubules with malignant transformation in a patient with Peutz-Jeghers syndrome.

scientific article published on January 2010

An update on PARP inhibitors for the treatment of cancer

scientific article

Audit of CA125 Follow-Up After First-Line Therapy for Ovarian Cancer

scientific article

Characterisation and correction of a mammalian cell mutant defective in late step of base excision repair

scientific article published on November 1, 1992

Differential effects of rapalogues, dual kinase inhibitors on human ovarian carcinoma cells in vitro

scientific article published on 18 May 2016

Diffusion-weighted MRI in Advanced Epithelial Ovarian Cancer: Apparent Diffusion Coefficient as a Response Marker

scientific article published on 01 October 2019

ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer

scientific article

Emerging treatment options for recurrent ovarian cancer: the potential role of olaparib

scientific article published on 03 September 2013

H2A Histone Family Member X (H2AX) Is Upregulated in Ovarian Cancer and Demonstrates Utility as a Prognostic Biomarker in Terms of Overall Survival

scientific article published on 02 September 2020

Identification of Cancer-Associated Circulating Cells in Anal Cancer Patients

scientific article published on 10 August 2020

Kinase Inhibitors and Ovarian Cancer

scientific article published on 12 September 2019

Liquid Biopsies in Lung Cancer: Four Emerging Technologies and Potential Clinical Applications

scientific article published on 07 March 2019

Management of asymptomatic patients on follow-up for ovarian cancer with rising CA-125 concentrations

scientific article published on September 2007

Maximal effort cytoreductive surgery for disseminated ovarian cancer in a UK setting: challenges and possibilities.

scientific article

Recurrent Ovarian Cancer: When and How to Treat ⬇️

scientific article published on December 1, 2011

Targeted anti-vascular therapies for ovarian cancer: current evidence ⬇️

scientific article

The pro-social neurohormone oxytocin reverses the actions of the stress hormone cortisol in human ovarian carcinoma cells in vitro

scientific article published on March 2016

Using serum CA125 to assess the activity of potential cytostatic agents in ovarian cancer

scientific article published on May 2014

Paulina is supported by:

About Paulina

Help